Geneos Wealth Management Inc. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$25,418
-19.3%
560
-0.2%
0.00%
-50.0%
Q2 2023$31,495
+238.0%
561
+172.3%
0.00%
+100.0%
Q1 2023$9,317
+11.3%
2060.0%0.00%0.0%
Q4 2022$8,374
-76.1%
206
-61.9%
0.00%
-50.0%
Q3 2022$35,000
-51.4%
541
-52.2%
0.00%
-50.0%
Q2 2022$72,000
+1.4%
1,131
-0.6%
0.00%
+33.3%
Q1 2022$71,000
-47.4%
1,138
-36.1%
0.00%
-40.0%
Q4 2021$135,000
-31.1%
1,782
+0.8%
0.01%
-37.5%
Q3 2021$196,000
-28.7%
1,767
+0.1%
0.01%
-27.3%
Q2 2021$275,000
+23.3%
1,766
+3.8%
0.01%
+83.3%
Q1 2021$223,000
+14.9%
1,7010.0%0.01%
-25.0%
Q4 2020$194,000
+106.4%
1,701
+51.7%
0.01%
+60.0%
Q3 2020$94,000
+14.6%
1,1210.0%0.01%0.0%
Q2 2020$82,000
+173.3%
1,121
+55.5%
0.01%
+150.0%
Q1 2020$30,000
-58.9%
721
-35.7%
0.00%
-50.0%
Q4 2019$73,000
+69.8%
1,121
+9.8%
0.00%
+33.3%
Q3 2019$43,000
-10.4%
1,0210.0%0.00%0.0%
Q2 2019$48,000
+33.3%
1,0210.0%0.00%
+50.0%
Q1 2019$36,000
+33.3%
1,0210.0%0.00%0.0%
Q4 2018$27,000
+237.5%
1,021
+410.5%
0.00%
+100.0%
Q3 2018$8,000
-68.0%
200
-63.5%
0.00%
-50.0%
Q1 2018$25,0005480.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$31,294,00031.24%
NEA Management Company, LLC 1,590,002$365,593,00010.56%
Ariose Capital Management Ltd 37,900$2,379,0009.30%
ARK Investment Management 9,404,071$590,294,0002.46%
NIA IMPACT ADVISORS, LLC 80,082$5,027,0002.44%
Nikko Asset Management Americas, Inc. 4,619,747$291,044,0002.14%
PLUSTICK MANAGEMENT LLC 50,000$3,139,0001.98%
Integral Health Asset Management, LLC 120,000$7,532,0001.96%
Valiant Capital Management, L.P. 240,683$15,108,0001.73%
Deuterium Capital Management, LLC 18,000$1,130,0001.45%
View complete list of CRISPR THERAPEUTICS AG shareholders